Related Experiment Videos
Effect of tenoxicam on inflammation and immune cellular function
M A Scheinberg1, J Santoro, M L Sanchez
1Disciplina de Reumatologia/Imunologia, Instituto do Câncer Arnaldo Vieira de Carvalho, São Paulo, Brasil.
Summary
Tenoxicam, a nonsteroidal anti-inflammatory drug, effectively inhibits neutrophil and monocyte immune cell movement to inflammatory sites. It does not impact interleukin-2 (IL-2) receptor expression or interleukin-1 (IL-1) release in these cells.
Area of Science:
- Immunopharmacology
- Inflammation research
- Drug discovery
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are known inhibitors of neutrophil activation.
- Tenoxicam is a novel oxicam-class NSAID with established clinical efficacy.
Purpose of the Study:
- To investigate the immunopharmacological effects of Tenoxicam on immune cell function.
- Specifically, to assess its impact on lymphocyte IL-2 receptor expression, monocyte chemotaxis and IL-1 release, and neutrophil chemotaxis.
Main Methods:
- In vitro and in vivo assessment of Tenoxicam's effects on immune cell functions.
- Evaluation of interleukin-2 (IL-2) receptor expression on lymphocytes.
- Measurement of monocyte chemotaxis and interleukin-1 (IL-1) release.
- Assessment of neutrophil chemotactic response to a standard stimulus.
Main Results:
- Tenoxicam demonstrated significant inhibition of neutrophil and monocyte chemotaxis in vitro.
- A partial inhibition of monocyte chemotaxis was observed in vivo.
- Tenoxicam did not affect IL-2 receptor expression on lymphocytes or IL-1 release from monocytes.
- The drug's inhibitory effect on cell mobilization to inflammatory sites was less evident after oral administration.
Conclusions:
- Tenoxicam exhibits immunomodulatory properties by inhibiting neutrophil and monocyte migration.
- The drug's mechanism does not involve modulation of IL-2 receptor expression or IL-1 release.
- Tenoxicam's clinical utility may be related to its ability to reduce inflammatory cell infiltration.